Asset Allocation

As of December 31, 2025.
Type % Net
Cash 12.03%
Stock 82.25%
Bond 5.75%
Convertible 0.00%
Preferred 0.00%
Other -0.02%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 93.90%
Mid 3.22%
Small 2.87%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 87.74%    % Emerging Markets: 0.02%    % Unidentified Markets: 12.24%

Americas 27.12%
27.07%
Canada 0.06%
United States 27.01%
0.05%
Colombia 0.00%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 9.75%
United Kingdom 0.03%
1.15%
Finland 0.00%
France 0.00%
Ireland 1.00%
Netherlands 0.10%
Norway 0.00%
Sweden 0.00%
Switzerland 0.04%
0.00%
8.57%
Israel 8.57%
Greater Asia 50.90%
Japan 0.05%
0.02%
Australia 0.02%
50.80%
Hong Kong 5.64%
Singapore 0.00%
South Korea 0.01%
Taiwan 45.15%
0.02%
China 0.02%
Thailand 0.00%
Unidentified Region 12.24%

Bond Credit Quality Exposure

AAA --
AA --
A --
BBB --
BB --
B --
Below B --
    CCC --
    CC --
    C --
    DDD --
    DD --
    D --
Not Rated --
Not Available --
Short Term --
No Data Available
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
7.43%
Materials
0.17%
Consumer Discretionary
3.02%
Financials
4.05%
Real Estate
0.19%
Sensitive
72.45%
Communication Services
4.43%
Energy
0.03%
Industrials
2.84%
Information Technology
65.15%
Defensive
12.60%
Consumer Staples
0.03%
Health Care
12.55%
Utilities
0.03%
Not Classified
7.51%
Non Classified Equity
0.02%
Not Classified - Non Equity
7.50%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 99.98%
Corporate 0.02%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term --
Less than 1 Year --
Intermediate --
1 to 3 Years --
3 to 5 Years --
5 to 10 Years --
Long Term --
10 to 20 Years --
20 to 30 Years --
Over 30 Years --
Other --
No Data Available
View Bond Maturity Exposure
Start Trial